Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
复制标题
戒烟和血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂以限制 2019 年冠状病毒病
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
A. Di Vincenzo
中科院分区：
文献类型：
--
作者：
M. Rossato;A. Di Vincenzo
我们饶有兴趣地阅读了小宫山和长谷川关于将戒烟作为限制2019冠状病毒病（COVID-19）大流行的公共卫生措施的必要性的论文。似乎很明显，需要重申的是，戒烟对于减少许多其他严重疾病是可取的，例如慢性肺病和心血管疾病以及某些类型的癌症，它们是发病率和死亡率的主要原因。全世界每年有800多万人死于吸烟，其中700多万人死于直接使用烟草，约100万人死于接触二手烟的非吸烟者。
We read with interest the paper by Komiyama and Hasegawa on the need for smoking cessation as a public health measure to limit the coronavirus disease 2019 (COVID-19) pandemic. It seems obvious to reiterate that smoking cessation is advisable to reduce many other severe conditions, such as chronic lung and cardiovascular diseases and some types of cancer, which are leading causes of morbidity and mortality. Cigarette smoking kills more than 8 million people each year worldwide, with more than 7 million of those deaths being the result of direct tobacco use and around 1 million occurring in non-smokers exposed to second-hand smoke.